SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001654954-22-015367
Filing Date
2022-11-15
Accepted
2022-11-15 16:06:11
Documents
13

Document Format Files

Seq Description Document Type Size
1 FORM S-3 drma_s3.htm S-3 344799
2 FORM OF SENIOR NOTE drma_ex45.htm EX-4.7 391640
3 FORM OF SUBORDINATED NOTE drma_ex46.htm EX-4.8 422393
4 OPINION OF LOWENSTEIN SANDLER LLP drma_ex51.htm EX-5.1 26702
5 CONSENT OF MAYER HOFFMAN drma_ex231.htm EX-23.1 2260
6 FILING FEES drma_ex107.htm EX-FILING FEES 21309
7 drma_ex51img8.jpg GRAPHIC 7625
8 drma_ex51img6.jpg GRAPHIC 4054
9 drma_ex51img5.jpg GRAPHIC 4054
10 drma_ex51img4.jpg GRAPHIC 4054
11 drma_ex51img3.jpg GRAPHIC 5039
12 drma_s3img3.jpg GRAPHIC 4871
13 drma_s3img2.jpg GRAPHIC 4842
  Complete submission text file 0001654954-22-015367.txt   1258521
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-268383 | Film No.: 221391204
SIC: 2834 Pharmaceutical Preparations